Volume 27, Number 3—March 2021
Research
Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July–August 2020
Table 4
Characteristic | Hospital |
Nursing home |
|||||
---|---|---|---|---|---|---|---|
No. | Seropositive, no. | Seropositive, % (95% CI) | No. | Seropositive, no. | Seropositive, % (95% CI) | ||
Aerosol-generating procedure frequency | |||||||
0 times per shift per week | 4,121 | 108 | 2.6 (2.2–3.2) | 858 | 93 | 10.8 (8.8–13.1) | |
1–5 times | 1,679 | 62 | 3.7 (2.8–4.7) | 114 | 25 | 21.9 (14.7–30.7) | |
6–10 times | 380 | 22 | 5.8 (3.7–8.6) | 36 | 7 | 19.4 (8.2–36.0) | |
11–25 times | 277 | 11 | 4.0 (2.0–7.0) | 23 | 4 | 17.4 (5.0–38.8) | |
>25 times | 366 | 19 | 5.2 (3.2–8.0) | 41 | 12 | 29.3 (16.1–45.5) | |
NA |
1,546 |
34 |
2.2 (1.5–3.1) |
422 |
55 |
13.0 (10.0–16.6) |
|
PPE use | |||||||
Never use PPE | 2,939 | 64 | 2.2 (1.7–2.8) | 322 | 19 | 5.9 (3.6–9.1) | |
Used PPE and reported frequency of needing complete PPE | |||||||
Daily | 1,809 | 66 | 3.7 (2.8–4.6) | 632 | 125 | 19.8 (16.7–23.1) | |
Few times a week | 1,860 | 75 | 4.0 (3.2–5.0) | 332 | 42 | 12.7 (9.3–16.7) | |
Less than once a week |
1,761 |
51 |
2.9 (2.2–3.8) |
208 |
10 |
4.8 (2.3–8.7) |
|
Use of PPE shortage protocol | |||||||
No shortage | 511 | 25 | 4.9 (3.2–7.1) | 238 | 28 | 11.8 (8.0–16.6) | |
Reuse | 934 | 21 | 2.3 (1.4–3.4) | 186 | 21 | 11.3 (7.1–16.7) | |
Extended use | 1,341 | 42 | 3.1 (2.3–4.2) | 253 | 45 | 17.8 (13.3–23.1) | |
Extended and reuse |
2,644 |
104 |
3.9 (3.2–4.8) |
495 |
83 |
16.8 (13.6–20.4) |
|
Donning/doffing training in past year | |||||||
Yes | 5,140 | 184 | 3.6 (3.1–4.1) | 1,135 | 170 | 15.0 (13.0–17.2) | |
No | 199 | 5 | 2.5 (0.8–5.8) | 15 | 3 | 20.0 (4.3–48.1) | |
Don't know | 91 | 3 | 3.3 (0.7–9.3) | 22 | 4 | 18.2 (5.2–40.3) |
*Significant linear trend of seropositivity with rising frequency of aerosol-generating procedures and decreasing frequency of needing complete PPE for hospital and nursing home settings (p<0.001 for all). NA, not applicable; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Page created: December 01, 2020
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.